NUVARING
0,12MG/0,015MG/24H VAG INS 3
SÚKL code | 0120188 |
---|---|
Name of the product | NUVARING |
_MA_MEDICATION_DETAIL_INFO_MED_NAME i | NUVARING |
Supplement | 0,12MG/0,015MG/24H VAG INS 3 |
Strenght | 0,12MG/0,015MG/24H |
Pharmaceutical form | Vaginal delivery system |
Package | 3 |
Route | Vaginal use |
Language of the pack | Czech |
Wrap type | Sachet |
Legal status | na lékařský předpis |
Active substance |
ETHINYLESTRADIOL (ETHINYLESTRADIOLUM) ETONOGESTREL (ETONOGESTRELUM) |
ATC group | G02BB01 |
ATC group name | VAGINÁLNÍ KROUŽEK S PROGESTINEM A ESTROGENEM |
Marketing authorisation information
Registration Number | 17/ 408/07-C |
---|---|
Type of MA | A mutual recognition procedure (MRP, DCP), where CZ is Concerned member state |
MA status | B - medicinal product after change, may be placed on the market for the period of 6 months (Placed on the market till) and used until expiration, not later than till the end of validity of the marketing authorisation (Valid till) |
Placed on the market till | 31. 12. 2018 |
MA Holder | N.V. Organon, Oss |
MA Holder country | NIZOZEMSKO |
Actual MA holder | Merck Sharp & Dohme B.V., Haarlem |
Actual MA holder country | NIZOZEMSKO |